Sarah Cramer, D.V.M., Ph.D.

Body

Dr. Cramer was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with University of Maryland and the National Cancer Institute, July 2011 – 2017. 

Prior to joining the program, Dr. Cramer received her B.A. in biology from St. Mary’s College of Maryland (2002) and her D.V.M. from Cornell University College of Veterinary Medicine (2008). She completed a residency in veterinary anatomic pathology at Oklahoma State University (2008 – 2011), and was board-certified by The American College of Veterinary Pathologists in 2011. In 2011, Dr. Cramer joined the CBSTP in partnership with the University of Maryland. She completed her dissertation research in the NCI Laboratory of Molecular Immunoregulation, headed by Scott Durum, Ph.D.

Dr. Cramer's research interests include pediatric oncology, IL-7R signaling pathways, leukemogenic genetic mutations, collaborative pathology, and digital image analysis of histology slides.

Image
Sarah Cramer, D.V.M., Ph.D.
Positions
Senior Pathologist, ToxPath Specialists (a StageBio Company), Frederick, MD
Research/Thesis
"Mutant IL-7R alpha and NRAS are sufficient to induce T-cell acute lymphoblastic leukemia."
Subheader
Diplomate, ACVP
Program Graduate 2017
Type
Graduate
University Partner
Cornell University (D.V.M.), University of Maryland (Ph.D.)
Year
2017